CDC Website CDC Website

To Join the NPIN community or

Home » Consortium for Design of TB Drug Regimens (UM1 Clinical Trial Not Allowed)

Consortium for Design of TB Drug Regimens (UM1 Clinical Trial Not Allowed)

The purpose of this FOA is to establish a consortium of tuberculosis (TB) preclinical and clinical experts to systematically refine preclinical models by analyses of relevant pre-clinical and clinical data, and to provide results from optimized models to identify the most promising combination regimens for clinical testing

Funding Organization
The US Department of Health and Human Services National Institutes of Health
Funding Category
Other Health-Related
TB
Support Types
Cooperative Agreements
Locations
National
Eligible Organizations
City Agencies
Colleges/Universities
Commercial Organizations
Community Based Organizations
County Agencies
Educational Organizations/Institutions
Federal Government Agencies
IRS 501 (c)(3) Organizations
Nonprofit Organizations
Public Health Departments/Social Services Departments
Religious Organizations
Research Institutions
State Agencies
Tribal Organizations
Application Due Date
2/7/23
Application Contact
Liz
Sihombing
Grants Financial Manager (NIAID)
240-669-5530
elizabeth.sihombing@nih.gov
Subjects
Clinical Research
Research
TB
TB Prevention
Audiences
At Risk Persons
Persons with TB

Fund Number: 

365581

Fund ID: 

RFA-AI-22-059

Last modified: 

9/21/22